These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1136 related articles for article (PubMed ID: 8815006)

  • 21. Independent regulation of tyrosinase by the hypopigmenting cytokines TGF beta1 and TNF alpha and the melanogenic hormone alpha-MSH in B16 mouse melanocytes.
    Martínez-Esparza M; Solano F; García-Borrón JC
    Cell Mol Biol (Noisy-le-grand); 1999 Nov; 45(7):991-1000. PubMed ID: 10644003
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of pyrroloquinoline quinone (PQQ) on melanogenic protein expression in murine B16 melanoma.
    Sato K; Toriyama M
    J Dermatol Sci; 2009 Feb; 53(2):140-5. PubMed ID: 19013771
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Inhibitory effect of arbutin on melanogenesis--biochemical study using cultured B16 melanoma cells].
    Akiu S; Suzuki Y; Asahara T; Fujinuma Y; Fukuda M
    Nihon Hifuka Gakkai Zasshi; 1991 May; 101(6):609-13. PubMed ID: 1920891
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Selective targeting of melanoma and APCs using a recombinant antibody with TCR-like specificity directed toward a melanoma differentiation antigen.
    Denkberg G; Lev A; Eisenbach L; Benhar I; Reiter Y
    J Immunol; 2003 Sep; 171(5):2197-207. PubMed ID: 12928363
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Potent selection of antigen loss variants of B16 melanoma following inflammatory killing of melanocytes in vivo.
    Sanchez-Perez L; Kottke T; Diaz RM; Ahmed A; Thompson J; Chong H; Melcher A; Holmen S; Daniels G; Vile RG
    Cancer Res; 2005 Mar; 65(5):2009-17. PubMed ID: 15753401
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tyrosinase mutants are capable of prodrug activation in transfected nonmelanotic cells.
    Simonova M; Wall A; Weissleder R; Bogdanov A
    Cancer Res; 2000 Dec; 60(23):6656-62. PubMed ID: 11118049
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Polymerization of 5,6-dihydroxyindole-2-carboxylic acid to melanin by the pmel 17/silver locus protein.
    Chakraborty AK; Platt JT; Kim KK; Kwon BS; Bennett DC; Pawelek JM
    Eur J Biochem; 1996 Feb; 236(1):180-8. PubMed ID: 8617263
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibitory effects of whisky congeners on melanogenesis in mouse B16 melanoma cells.
    Ohguchi K; Koike M; Suwa Y; Koshimizu S; Mizutani Y; Nozawa Y; Akao Y
    Biosci Biotechnol Biochem; 2008 Apr; 72(4):1107-10. PubMed ID: 18391453
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Characterization of gene regulatory elements for selective gene expression in human melanoma cells.
    Artuc M; Nürnberg W; Czarnetzki BM; Schadendorf D
    Biochem Biophys Res Commun; 1995 Aug; 213(2):699-705. PubMed ID: 7646526
    [TBL] [Abstract][Full Text] [Related]  

  • 30. NDRG2 gene expression in B16F10 melanoma cells restrains melanogenesis via inhibition of Mitf expression.
    Kim A; Yang Y; Lee MS; Yoo YD; Lee HG; Lim JS
    Pigment Cell Melanoma Res; 2008 Dec; 21(6):653-64. PubMed ID: 19067970
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Paclitaxel stimulates melanogenesis in B16-F1 melanoma cells.
    Bicamumpaka C; Pagé M
    Anticancer Res; 1998; 18(6A):4101-4. PubMed ID: 9891452
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Drug sensitivity ("suicide") genes for selective cancer chemotherapy.
    Moolten FL
    Cancer Gene Ther; 1994 Dec; 1(4):279-87. PubMed ID: 7543006
    [No Abstract]   [Full Text] [Related]  

  • 33. Regulation of tyrosinase gene expression by cAMP in B16 melanoma cells involves two CATGTG motifs surrounding the TATA box: implication of the microphthalmia gene product.
    Bertolotto C; Bille K; Ortonne JP; Ballotti R
    J Cell Biol; 1996 Aug; 134(3):747-55. PubMed ID: 8707852
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tyrosinase isoenzymes in mammalian melanocytes. 2. Differential activation by alpha-melanocyte-stimulating hormone.
    Valverde P; Garcia-Borron JC; Jimenez-Cervantes C; Solano F; Lozano JA
    Eur J Biochem; 1993 Oct; 217(2):541-8. PubMed ID: 7901010
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Transcriptional induction of the melanocyte-stimulating hormone receptor in brain metastases of murine K-1735 melanoma.
    Radinsky R; Beltran PJ; Tsan R; Zhang R; Cone RD; Fidler IJ
    Cancer Res; 1995 Jan; 55(1):141-8. PubMed ID: 7805024
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A comparison of the properties of different retroviral vectors containing the murine tyrosinase promoter to achieve transcriptionally targeted expression of the HSVtk or IL-2 genes.
    Vile R; Miller N; Chernajovsky Y; Hart I
    Gene Ther; 1994 Sep; 1(5):307-16. PubMed ID: 7584096
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In vitro modulation of proliferation and melanization of melanoma cells by citrate.
    Bhatnagar V; Srirangam A; Abburi R
    Mol Cell Biochem; 1998 Oct; 187(1-2):57-65. PubMed ID: 9788743
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Molecular mechanism of tyrosinase regulation by L-dopa in hamster melanoma cells.
    Slominski A; Costantino R
    Life Sci; 1991; 48(21):2075-9. PubMed ID: 1903481
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A pilot study of immunization with HLA-A2 matched allogeneic melanoma cells that secrete interleukin-2 in patients with metastatic melanoma.
    Hum Gene Ther; 1992 Dec; 3(6):677-90. PubMed ID: 1482708
    [No Abstract]   [Full Text] [Related]  

  • 40. Bystander killing of melanoma cells using the human tyrosinase promoter to express the Escherichia coli purine nucleoside phosphorylase gene.
    Hughes BW; Wells AH; Bebok Z; Gadi VK; Garver RI; Parker WB; Sorscher EJ
    Cancer Res; 1995 Aug; 55(15):3339-45. PubMed ID: 7614469
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 57.